Search Results
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Kirsty G Pringle in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Sarah J Delforce in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Yu Wang in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Katie A Ashton in
Google Scholar
PubMed
Search for other papers by Anthony Proietto in
Google Scholar
PubMed
Search for other papers by Geoffrey Otton in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by C Caroline Blackwell in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Division of Molecular Medicine, Pathology North, Newcastle, New South Wales, Australia
Search for other papers by Rodney J Scott in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Eugenie R Lumbers in
Google Scholar
PubMed
the RAS which, via the angiotensin II type 1 receptor (AGTR1), stimulates angiogenesis and cell proliferation ( 4 , 5 , 6 ). In tissues, inactive prorenin is non-proteolytically activated by binding to the (pro)renin receptor (ATP6AP2), so it forms
Priority Research Centre for Reproductive Sciences, University of Newcastle, Newcastle, New South Wales, Australia
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Sarah J Delforce in
Google Scholar
PubMed
Priority Research Centre for Reproductive Sciences, University of Newcastle, Newcastle, New South Wales, Australia
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Eugenie R Lumbers in
Google Scholar
PubMed
Priority Research Centre for Reproductive Sciences, University of Newcastle, Newcastle, New South Wales, Australia
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Celine Corbisier de Meaultsart in
Google Scholar
PubMed
Search for other papers by Yu Wang in
Google Scholar
PubMed
Search for other papers by Anthony Proietto in
Google Scholar
PubMed
Search for other papers by Geoffrey Otton in
Google Scholar
PubMed
Search for other papers by Jim Scurry in
Google Scholar
PubMed
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Priority Research Centre for Cancer, University of Newcastle, Newcastle, New South Wales, Australia
Search for other papers by Nicole M Verrills in
Google Scholar
PubMed
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Hunter Area Pathology Service, John Hunter Hospital, Newcastle, New South Wales, Australia
Search for other papers by Rodney J Scott in
Google Scholar
PubMed
Priority Research Centre for Reproductive Sciences, University of Newcastle, Newcastle, New South Wales, Australia
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Kirsty G Pringle in
Google Scholar
PubMed
Ang I by angiotensin-converting enzyme (ACE), can act on the angiotensin II type 1 receptor (AGTR1) to stimulate angiogenesis and cell proliferation. There is also an additional RAS pathway that opposes the Ang II/AGTR1 pathway. This is the ACE2/Ang(1
Search for other papers by Lang Qin in
Google Scholar
PubMed
Search for other papers by Xiaoming Zhu in
Google Scholar
PubMed
Search for other papers by Xiaoxia Liu in
Google Scholar
PubMed
Search for other papers by Meifang Zeng in
Google Scholar
PubMed
Search for other papers by Ran Tao in
Google Scholar
PubMed
Search for other papers by Yan Zhuang in
Google Scholar
PubMed
Search for other papers by Yiting Zhou in
Google Scholar
PubMed
Shanghai Pituitary Tumor Center, Shanghai, China
Search for other papers by Zhaoyun Zhang in
Google Scholar
PubMed
Search for other papers by Yehong Yang in
Google Scholar
PubMed
Search for other papers by Yiming Li in
Google Scholar
PubMed
Shanghai Pituitary Tumor Center, Shanghai, China
Search for other papers by Yongfei Wang in
Google Scholar
PubMed
Search for other papers by Hongying Ye in
Google Scholar
PubMed
. ( https://doi.org/10.3109/07853890008995944 ) 10.3109/07853890008995944 11028685 23 Wassmann S Hilgers S Laufs U Bohm M Nickenig G. Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction
Search for other papers by Frans H H Leenen in
Google Scholar
PubMed
Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA
Search for other papers by Mordecai P Blaustein in
Google Scholar
PubMed
Search for other papers by John M Hamlyn in
Google Scholar
PubMed
White R Chen A Ahmad M Leenen FHH. Mineralocorticoid and angiotensin II type 1 receptors in the subfornical organ mediate angiotensin II: induced hypothalamic reactive oxygen species and hypertension . Neuroscience 2016 329 112
Search for other papers by Wioletta Pijacka in
Google Scholar
PubMed
Search for other papers by Morag G Hunter in
Google Scholar
PubMed
Search for other papers by Fiona Broughton Pipkin in
Google Scholar
PubMed
Search for other papers by Martin R Luck in
Google Scholar
PubMed
Horn LC Stepan H . Angiotensin II type 1 receptor has impact on murine placentation . Placenta 2008 29 905 – 909 . ( doi:10.1016/j.placenta.2008.07.006 ). 35 Arce ME Sanchez SI Aguilera FL Seguin LR Seltzer AM Ciuffo GM
Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China
Search for other papers by Xu Chen in
Google Scholar
PubMed
Search for other papers by Yi Tang in
Google Scholar
PubMed
Search for other papers by Shen Chen in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China
Search for other papers by Wenhua Ling in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China
Search for other papers by Qing Wang in
Google Scholar
PubMed
S Basu RC Cheah PL Salim A Mohamed R . Susceptibility and gene interaction study of the angiotensin II type 1 receptor (AGTR1) gene polymorphisms with non-alcoholic fatty liver disease in a multi-ethnic population . PLoS ONE 2013 8 e58538
Search for other papers by Renea A Taylor in
Google Scholar
PubMed
Search for other papers by Jennifer Lo in
Google Scholar
PubMed
Search for other papers by Natasha Ascui in
Google Scholar
PubMed
Search for other papers by Matthew J Watt in
Google Scholar
PubMed
change in obese vs lean individuals. AngII, angiotensin II; AT1 1 R, angiotensin II type 1 receptor; PEDF, pigment epithelium-derived factor; RTK, receptor tyrosine kinase Obesity-driven inflammation and prostate cancer Adipose tissue becomes increasingly
Search for other papers by M L M Barreto-Chaves in
Google Scholar
PubMed
Search for other papers by N Senger in
Google Scholar
PubMed
Search for other papers by M R Fevereiro in
Google Scholar
PubMed
Search for other papers by A C Parletta in
Google Scholar
PubMed
Search for other papers by A P C Takano in
Google Scholar
PubMed
Karageorgiou H Cokkinos DV . Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning . Hormone and Metabolic Research 2005 37 500 – 504 . ( https://doi.org/10.1055/s-2005
Search for other papers by Madalena von Hafe in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar São João, Porto, Portugal
Search for other papers by João Sergio Neves in
Google Scholar
PubMed
Search for other papers by Catarina Vale in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar São João, Porto, Portugal
Search for other papers by Marta Borges-Canha in
Google Scholar
PubMed
Search for other papers by Adelino Leite-Moreira in
Google Scholar
PubMed
) 10.1056/NEJM200102153440707 16 Fukuyama K Ichiki T Takeda K Tokunou T Lino N Masuda S Ishibashi M Egashira K Shimokawa H Hirano K , et al . Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone . Hypertension 2003 41